TRIDENT LIFELINE
|
TRIDENT LIFELINE Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | |
---|---|---|
Profit Before Tax | ₹6.58 Cr | ₹2.98 Cr |
Adjustment | ₹0.08 Cr | ₹0.33 Cr |
Changes In working Capital | ₹-24 Cr | ₹-3.67 Cr |
Cash Flow after changes in Working Capital | ₹-17 Cr | ₹-0.36 Cr |
Cash Flow from Operating Activities | ₹-17 Cr | ₹-0.21 Cr |
Cash Flow from Investing Activities | ₹-6.94 Cr | ₹-0.45 Cr |
Cash Flow from Financing Activities | ₹38 Cr | ₹0.80 Cr |
Net Cash Inflow / Outflow | ₹14 Cr | ₹0.14 Cr |
Opening Cash & Cash Equivalents | ₹0.16 Cr | ₹0.01 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
Effect of Foreign Exchange Fluctuations | - | - |
Closing Cash & Cash Equivalent | ₹14 Cr | ₹0.16 Cr |
Compare Cashflow Statement of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹194.4 Cr | -4.5% | 5.6% | 14.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | -4.5% |
5.6% |
14.4% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses